Molecular Formula | C21H18F3N5O |
Molar Mass | 413.4 |
Density | 1.456±0.06 g/cm3(Predicted) |
Solubility | DMSO |
Appearance | White solid |
Color | white |
pKa | 14.51±0.70(Predicted) |
Storage Condition | 2-8°C |
Use | Aurora kinase inhibitor III is a potent inhibitor of Aurora A kinase (IC50 = 42 nM).1 It is selective for Aurora A over BMX, BTK, IGF-1R, c-Src, TRKB, SYK, and EGFR. |
Target | Aurora A |
WGK Germany | 3 |
Reference Show more | 1. Tari LW, et al. Structural basis for the inhibition of Aurora A kinase by a novel class of high affinitydisubstituted pyrimidine inhibitors. Bioorg Med Chem Lett. 2007 Feb 1;17(3):688-91. |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 2.419 ml | 12.095 ml | 24.19 ml |
5 mM | 0.484 ml | 2.419 ml | 4.838 ml |
10 mM | 0.242 ml | 1.209 ml | 2.419 ml |
5 mM | 0.048 ml | 0.242 ml | 0.484 ml |
Biological activity | Aurora kinase inhibitor III is a potent Aurora A kinase inhibitor with an IC50 of 42 nM. It has 386, 3550, 591, 1980, 2510, 887 and> 10,000 nM for BMX, BTK, IGF-1R, c-Src, TRKB, SYK and EGFR respectively. |
Target | Value |
Aurora A (Cell-free assay) | 42 nM |
BMX (Cell-free assay) | 386 nM |
IGF-1R (Cell-free assay) | 591 nM |
SYK (Cell-free assay) | 887 nM |
c-Src (Cell-free assay) | 1980 nM |